Search Results for 'Top 10 Biopharma'
-
-
2017 Annual Outsourcing Survey
Herein are the results of our 2017 Annual Outsourcing Survey, where we call on you, the reader.05.09.17
-
-
Biosimilars | Capsules
Top 10 Biopharma Report
Our annual look at the 10 biggest players in the Biopharmaceutical marketplace07.17.13
-
Drug Development | Process Validation | Validation
-
Biosimilars | Capsules
Top 10 Biopharma Report
Our annual look at the 10 biggest players in the Biopharmaceutical marketplace07.16.13
-
-
Capsules
-
Capsules
2011 Top 10 Biopharma Companies
Our annual look at the 10 biggest biopharmaceutical players07.19.12
-
Capsules
2008 Top 20 Pharma Companies
The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007.07.19.12
-
Capsules
2009 Top 20 Pharma Companies
They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top!07.19.12
-
Capsules
-
Capsules
2012 Top 10 Biopharma Companies
Our annual look at the 10 biggest players in the Biopharmaceutical marketplace07.19.12
-
Biosimilars | Drug Discovery
-
Biosimilars | Injectables
-
Capsules
Top 10 Biopharma Companies
Our annual look at the 10 biggest players in the Biopharmaceutical marketplaceGil Y. Roth, Editor 07.18.12
-
QA/QC | Regulatory Affairs | Supply Chain | Validation
2012 Annual Outsourcing Survey
Welcome to our 8th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents, by company type & job function:Gil Roth, Editor 05.15.12
-
-
-
-
-
-
Injectables | Vials
-
Clinical Trials
-
Drug Development | Fill/Finish
-
Fill/Finish
-
Biosimilars | Chemistry
-
Capsules
The Top 10 Biopharmaceutical Companies
Our annual look at the 10 biggest biopharmaceutical playersGil Y. Roth 07.14.11
-
Bioassay Development | Breaking News | Clinical Trials | Drug Development | GMPs/GCPs | Inspections | Methods Development | Process Development | Regulatory Affairs | Toxicology | Trials & Filings
Merck Serono Abandons Cladribine
Cancels NDA and MAA and withdraws MS treatment from approved marketsGil Roth 06.22.11
-
QA/QC | Regulatory Affairs | Supply Chain | Validation
2011 Annual Outsourcing Survey
Welcome to our 7th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of the respondents, by company type & job function:05.15.11
-
Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Inspections | Lyophilization | Process Development | Regulatory Affairs | Serialization | Supply Chain
2011 Annual Outsourcing Survey
Welcome to our 7th Annual Contract Pharma Outsourcing Survey! More than 200 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll.Gil Y. Roth 05.03.11
-
Research
Whether you're looking for the latest whitepapers or our industry-leading Top Companies reports and surveys, the categories below offer some of the most valuable information around.02.28.11
-
R&D
-
Capsules
-
Capsules
-
QA/QC | Regulatory Affairs | Supply Chain | Validation
2010 Annual Outsourcing Survey
Welcome to our 6th Annual Contract Pharma Outsourcing Survey! More than 350 sponsor-side respondents offered up their opinions on outsourcing trends for this year’s poll. Here’s a breakdown of the respondents, by company type & job function:Gil Roth, Editor 05.15.10
-
2010 Annual Outsourcing Survey
Welcome to our 6th Annual Contract Pharma Outsourcing Survey! More than 350 sponsor-side respondents offered up their opinions on outsourcing trends for this year’s poll. Here’s a breakdown of the respondents, by company type & job function:Gil Y. Roth 05.11.10
-
-
-
Capsules
2009 Top 10 Biopharmaceutical Companies Report
This edition of the Top 10 Biopharmas marks the end of an era. After this year, we’ll no longer be able to pencil in Amgen as our #1 biopharma, since Roche is poised to take that slot. A lot of major pharmas have talked about “becoming a global biopharma.07.15.09
-
Capsules
2009 Top 20 Pharmaceutical Companies Report
They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top!07.15.09
-
-
2009 Annual Outsourcing Survey
Welcome to our 5th Annual Contract Pharma Outsourcing Survey! More than 175 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of respondents by company type:Gil Roth, Editor 05.15.09
-
-
Capsules
2008 Top 20 Pharmaceutical Companies Report
The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007.07.18.08
-
Capsules
2008 Top 10 Biopharmaceutical Companies Report
After years of producing this report, I’ve finally settled on definitive criteria for the Top Biopharma ranks! After consulting with Ronald A. Rader, president of the Biotechnology Information Institute, I decided that a Top Biopharma company is one that makes more than 40% of its drug revenues by selling biologic products, including biotherapeutics, vaccines and other proteins.07.18.08
-
2007 Top 10 Biopharmaceutical Companies Report
Warts and all, Amgen remains at the apex of the Top 10 Biopharma rankings. The first half of 2007 was none too kind to the top gun, but Amgen still has a comfortable lead over its competitors on this list.Gil Roth 07.19.07
-
-
2006 Top 10 Biopharmaceutical Companies Report
Amgen continues to rule the Top 10 Biopharma rankings, but 2005 saw a couple of players make great strides. Genentech and Gilead continued to post huge gains (+46% each) on the strength of their oncology and HIV drugs, respectively.07.25.06
-
